453 related articles for article (PubMed ID: 19304584)
1. Polypoidal choroidal vasculopathy and late geographic hyperfluorescence on indocyanine green angiography.
Kang SW; Chung SE; Shin WJ; Lee JH
Br J Ophthalmol; 2009 Jun; 93(6):759-64. PubMed ID: 19304584
[TBL] [Abstract][Full Text] [Related]
2. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability.
Sasahara M; Tsujikawa A; Musashi K; Gotoh N; Otani A; Mandai M; Yoshimura N
Am J Ophthalmol; 2006 Oct; 142(4):601-7. PubMed ID: 17011852
[TBL] [Abstract][Full Text] [Related]
3. Development of polypoidal choroidal vasculopathy in unaffected fellow eyes.
Kim YT; Kang SW; Chung SE; Kong MG; Kim JH
Br J Ophthalmol; 2012 Sep; 96(9):1217-21. PubMed ID: 22760488
[TBL] [Abstract][Full Text] [Related]
4. Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab.
Stangos AN; Gandhi JS; Nair-Sahni J; Heimann H; Pournaras CJ; Harding SP
Am J Ophthalmol; 2010 Nov; 150(5):666-73. PubMed ID: 20719300
[TBL] [Abstract][Full Text] [Related]
5. Structure of polypoidal choroidal vasculopathy studied by colocalization between tomographic and angiographic lesions.
Kim JH; Kang SW; Kim TH; Kim SJ; Ahn J
Am J Ophthalmol; 2013 Nov; 156(5):974-980.e2. PubMed ID: 23958701
[TBL] [Abstract][Full Text] [Related]
6. Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration.
Kikuchi M; Nakamura M; Ishikawa K; Suzuki T; Nishihara H; Yamakoshi T; Nishio K; Taki K; Niwa T; Hamajima N; Terasaki H
Ophthalmology; 2007 Sep; 114(9):1722-7. PubMed ID: 17400294
[TBL] [Abstract][Full Text] [Related]
7. Improvement of angiographic findings of polypoidal choroidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months.
Hikichi T; Ohtsuka H; Higuchi M; Matsushita T; Ariga H; Kosaka S; Matsushita R; Takami K
Am J Ophthalmol; 2010 Nov; 150(5):674-682.e1. PubMed ID: 20691424
[TBL] [Abstract][Full Text] [Related]
8. Polypoidal choroidal vasculopathy in Taiwanese patients.
Chang YC; Wu WC
Ophthalmic Surg Lasers Imaging; 2009; 40(6):576-81. PubMed ID: 19928723
[TBL] [Abstract][Full Text] [Related]
9. [Polypoidal choroidal vasculopathy--a rare form of choroidal neovascularization].
Weglarz M; Karska-Basta I; Kubicka-Trzaska A; Romanowska-Dixon B
Klin Oczna; 2009; 111(4-6):145-8. PubMed ID: 19673446
[TBL] [Abstract][Full Text] [Related]
10. Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions.
Tsuchiya D; Yamamoto T; Kawasaki R; Yamashita H
Retina; 2009; 29(7):960-5. PubMed ID: 19491727
[TBL] [Abstract][Full Text] [Related]
11. Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture, Japan.
Honda S; Imai H; Yamashiro K; Kurimoto Y; Kanamori-Matsui N; Kagotani Y; Tamura Y; Yamamoto H; Ohoto S; Takagi H; Uenishi M; Negi A
Ophthalmologica; 2009; 223(5):333-8. PubMed ID: 19478533
[TBL] [Abstract][Full Text] [Related]
12. Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration.
Hayashi H; Yamashiro K; Tsujikawa A; Ota M; Otani A; Yoshimura N
Am J Ophthalmol; 2009 Jul; 148(1):83-9.e1. PubMed ID: 19327745
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy.
Lai TY; Lee GK; Luk FO; Lam DS
Retina; 2011 Sep; 31(8):1581-8. PubMed ID: 21610566
[TBL] [Abstract][Full Text] [Related]
14. Polypoidal choroidal vasculopathy with large vascular network.
Tateiwa H; Kuroiwa S; Gaun S; Arai J; Yoshimura N
Graefes Arch Clin Exp Ophthalmol; 2002 May; 240(5):354-61. PubMed ID: 12073058
[TBL] [Abstract][Full Text] [Related]
15. Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types.
Kawamura A; Yuzawa M; Mori R; Haruyama M; Tanaka K
Acta Ophthalmol; 2013 Sep; 91(6):e474-81. PubMed ID: 23848133
[TBL] [Abstract][Full Text] [Related]
16. Punctate hyperfluorescent spots associated with polypoidal choroidal vasculopathy on indocyanine green angiography.
Kim H; Lee JH; Kwon KY; Byeon SH; Lee SC; Lee CS
Ophthalmic Surg Lasers Imaging Retina; 2015 Apr; 46(4):423-7. PubMed ID: 25970862
[TBL] [Abstract][Full Text] [Related]
17. Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy.
Ueno C; Gomi F; Sawa M; Nishida K
Retina; 2012; 32(10):2006-13. PubMed ID: 22772392
[TBL] [Abstract][Full Text] [Related]
18. Understanding indocyanine green angiography in polypoidal choroidal vasculopathy: the group experience with digital fundus photography and confocal scanning laser ophthalmoscopy.
Cheung CM; Lai TY; Chen SJ; Chong V; Lee WK; Htoon H; Ng WY; Ogura Y; Wong TY
Retina; 2014 Dec; 34(12):2397-406. PubMed ID: 25072645
[TBL] [Abstract][Full Text] [Related]
19. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y
Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
[TBL] [Abstract][Full Text] [Related]
20. Punctate hyperfluorescence spot as a common choroidopathy of central serous chorioretinopathy and polypoidal choroidal vasculopathy.
Park SJ; Kim BH; Park KH; Woo SJ
Am J Ophthalmol; 2014 Dec; 158(6):1155-1163.e1. PubMed ID: 25127698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
